Determination of BRCAness Phenotype in Breast Tumors for the Appointment of Neoadjuvant Chemotherapy Based on Platinum and Taxanes von Tsyganov, Matvey Mihajlovich, Ibragimova, Marina K, Garbukov, Evgeniy Y, Bragina, Olga D, Karchevskaya, Ariana A, Usynin, Evgeny A, Litvyakov, Nikolai V

Volltext

Molecular Protein and Expression Profile in the Primary Tumors of Clear Cell Renal Carcinoma and Metastases von Spirina, Liudmila V, Yurmazov, Zahar A, Gorbunov, Alexey K, Usynin, Evgeny A, Lushnikova, Nadezhda A, Kovaleva, Irina V

Volltext

Targeting of the AKT/m-TOR Pathway: Biomarkers of Resistance to Cancer Therapy--
AKT/m-TOR Pathway and Resistance to Cancer Therapy von Spirina, Liudmila V, Kondakova, Irina V, Tarasenko, Natalia V, Slonimskaya, Elena M, Usynin, Evgeny A, Gorbunov, Alexey K, Yurmazov, Zahar A, Chigevskaya, Svetlana Yu

Volltext

Progesterone Receptor Expression in the Benign Prostatic Hyperplasia and Prostate Cancer Tissues, Relation with Transcription, Growth Factors, Hormone Reception and Components of t... von Spirina, Liudmila V, Kovaleva, Irina V, Usynin, Evgeny A., Gorbunov, Alexey K, Kondakova, Irina V

Volltext

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial von Smith, Matthew R, Scher, Howard I, Sandhu, Shahneen, Efstathiou, Eleni, Lara, Primo N, Yu, Evan Y, Chi, Kim N, Ståhl, Olof, Olmos, David, Danila, Daniel C, Espina, Byron M, Zhao, Xin, Urtishak, Karen A, Francis, Peter, Lopez-Gitlitz, Angela, Parnis, Francis, Horvath, Lisa G., Steer, Christopher, Marx, Gavin, Sandhu, Shahneen, Ferguson, Thomas, Luyten, Daisy, Lumen, Nicolaas, Dirix, Luc, Goeminne, Jean-Charles, Gil, Thierry, Vulsteke, Christof, Kussumoto, Celio, Franke, Fabio A., Martinelli de Oliveira, Fabricio Augusto, Pereira de Santana Gomes, Andrea Juliana, Preto, Daniel D'Almeida, Zucca, Luis Eduardo, Borges, Giuliano Santos, Murad, Andre M., Saad, Fred, Chi, Kim N., Fradet, Yves, Fleshner, Neil E., Emmenegger, Urban, Brasso, Klaus, Culine, Stephane, Thiery-Vuillemin, Antoine, Joly, Florence, Fléchon, Aude, Hilgers, Werner, Borchiellini, Delphine, Barthélémy, Philippe, Berger, Raanan, Mermershtain, Wilmosh, Peer, Avivit, Sella, Avishay, Voortman, Johannes, Aarts, Maureen J., Gietema, Jourik A., Choi, Young-Deuk, Gafanov, Rustem A., Kopyltsov, Evgeniy, Carles, Joan, Mellado, Begoña, Maroto, José Pablo, García-Donás, Jesús, Rodríguez Moreno, Juan Francisco, Durán, Ignacio, Pérez-Valderrama, Begoña, Castro, Elena, Olmos, David, Méndez-Vidal, María José, Muñoz-Langa, José, Herranz, Urbano Anido, Puente Vázquez, Javier, Castellanos, Enrique, Hellström, Martin, Widmark, Anders, Lissbrant, Ingela Franck, Jellvert, Åsa, Külich, Cecilia, Blom, René, Kang, Chih-Hsiung, Ou, Yen-Chuan, Wang, Shian-Shiang, Attard, Gerhardt, Bahl, Amit, Kellati, Prasad, Parikh, Omi, Srinivasan, Rajaguru, Lester, Jason F., Staffurth, John N., Cheng, Heather H., Efstathiou, Eleni, Pilié, Patrick G., George, Daniel J., Karsh, Lawrence I., Kelly, W. Kevin, Danila, Daniel C., Smith, Matthew R., Heath, Elisabeth I., Vaishampayan, Ulka N., Emamekhoo, Hamid, Pinski, Jacek K.

Volltext

Effect of Targeted Therapy With Pazopanib on Expression Levels of Transcription, Growth Factors and Components of AKT/m-TOR Signaling Pathway in Patients with Renal Cell Carcinoma von Spirina, Liudmila V, Usynin, Evgeny A, Yurmazov, Zahar A, Slonimskaya, Elena M, Kondakova, Irina V

Volltext

Toxicity and safety of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell cancer: The Russian phase IV observational study von Volkova, Maria I., Kalpinskiy, Alexey S., Goncharova, Olesya A., Menshikov, Konstantin V., Karabina, Elena V., Dergunov, Aleksand S., Polshina, Natalya I., Alexandrova, Elena N., Lebedinets, Andrey A., Panov, Alexey К., Sultanbaev, Alexander V., Usynin, Evgeny A., Volkonskiy, Mikhail V., Mikhalyuk, Viktorya V., Zykov, Ruslan A., Anzhiganova, Yulia V., Gusniev, Magomed A., Igumnova, Elena N., Kuzmicheva, Svetlana V., Pokataev, Ilya A., Olshanskaya, Anna S., Pervakova, Natalia I., Parsadanova, Elvira L., Sannikova, Tatyana A., Bystrov, Alexandr A., Dubovichenko, Daria M., Miliausha, Mukhitova R., Chubenko, Viacheslav A., Shkret, Konstantin A., Gorshenina, Mariya N., Davlatova, Mavzhuda К., Kosareva, Alina E., Lutoshkina, Olga A., Maslova, Oxana A., Makhnutina, Maria V., Mishina, Anna V., Murzalina, Makhabbat Zh, Podyacheva, Oksana A., Kalinin, Sergey A., Mailyan, Ovsep A., Safarova, Alfiya R., Semenova, Ksenia O., Strokova, Mariya A., Urashkina, Ekaterina Yu, Shmygina, Olesya S.

Volltext

Molecular Markers of Kidney Cancer Progression, Association with Efficiency of Pazopanib Therapy von Spirina, Liudmila V., Usynin, Evgeny A., Kondakova, Irina V., Yurmazov, Zahar A., Slonimskaya, Elena M.

Volltext

Regulation of Immunity in Clear Cell Renal Carcinoma: Role of PD-1, PD-L1, and PD-L2 von Spirina, Liudmila, Yurmazov, Zahar, Usynin, Evgeny, Kondakova, Irina, Ladutko, Ekaterine, Choynzonov, Evgeny

Volltext

Determination of the limiting values of the laser parameters to heat treatment of powder carbon steels surface von Oglezneva, Svetlana, Morozov, Evgeny, Usynin, Evgeny

Volltext

P-54 - Clinical translation of the GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26 for targeting prostate tumors von Orlova, Anna, Abouzayed, Ayman, Rinne, Sara, Lushnikova, Nadezhda, Usynin, Evgeny, Doroshenko, A, Borin, Jesper, Sorensen, Jens, Tolmachev, Vladimir, Chernov, Vladimir, Rybina, Anastasia

Volltext

Clinical translation of the GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26 for targeting prostate tumors von Orlova, Anna, Abouzayed, Ayman, Rinne, Sara, Lushnikova, Nadezhda, Usynin, Evgeny, Doroshenko, A, Borin, Jesper, Sorensen, Jens, Tolmachev, Vladimir, Chernov, Vladimir, Rybina, Anastasia

Volltext

Phase I trial for SPECT imaging of GRPR expression in malignant tumors using [99mTc]Tc-maSSS-PEG2-RM26 prepared using one-pot labeling kit von Orlova, Anna, Rybina, Anastasia, Abouzayed, Ayman, Rinne, Sara, Zelchan, Roman, Medvedeva, Anna, Bragina, Olga, Lushnikova, Nadezhda, Doroshenko, A., Usynin, Evgeny, Tashireva, Liubov, Vtorushin, Sergei, Sorensen, Jens, Chernov, Vladimir, Tolmachev, Vladimir

Volltext

Clinical translation of the GRPR antagonist [Tc-99m]Tc-maSSS-PEG(2)-RM26 for targeting prostate tumors von Orlova, Anna, Abouzayed, Ayman, Rinne, Sara, Lushnikova, Nadezhda, Usynin, Evgeny, Doroshenko, A., Borin, Jesper, Sorensen, Jens, Tolmachev, Vladimir, Chernov, Vladimir, Rybina, Anastasia

Volltext

Safety of Pembroria® during non-medical switching from Keytruda® in patients with advanced malignant neoplasms of various localizations: the REFLECTION real-world study von Choynzonov, Evgeny L., Fedenko, Alexander A., Falaleeva, Natalia A., Andreeva, Tatiana V., Afanas'ev, Sergei G., Bakaev, Zelimkhan A., Valiev, Danila I., Volkov, Aleksandr A., Kolomiets, Larisa A., Krashikhina, Tatiana V., Miller, Sergei V., Mikhaliuk, Viktoriia V., Ogloblin, Andrei N., Orlova, Svetlana A., Pataliak, Stanislav V., Pokataev, Ilya A., Popova, Nataliia O., Rebrina, Olesia V., Safin, Rustem N., Stradaeva, Irina Iu, Trefilova, Iuliia V., Usol'tseva, Inessa S., Usynin, Evgenii A., Sharov, Sergey V., Iukal'chuk, Denis Iu, Iasieva, Aishat R.

Volltext

Efficacy and safety of lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: Russian multicenter observational... von Volkova, Maria, Abdelgafur, Ahmed, Amoev, Zurab, Aivazov, Magomed, Babina, Ksenia Gennadievna, Borisov, Pavel S., Evstigneeva, Irina, Samuseva, Olga Igorevna, Kalpynsky, Alexei, Karabina, Elena, Kirdakova, Natalia, Kuzmina, Evgeniya, Latipova, Dilorom H., Ovchinnikova, Elena G., Olshanskaya, Anna Sergeevna, Protsenko, Svetlana, Semiglazova, Tatiana, Smirnov, Roman, Usynin, Evgeny, Chernyakova, Irina

Volltext